These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15928417)

  • 1. Safety and immunogenicity of the intradermal Thai red cross (2-2-2-0-1-1) post exposure vaccination regimen in the Indian population using purified chick embryo cell rabies vaccine.
    Chhabra M; Ichhpujani RL; Bhardwaj M; Tiwari KN; Panda RC; Lal S
    Indian J Med Microbiol; 2005 Jan; 23(1):24-8. PubMed ID: 15928417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
    Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C
    Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potency requirements of rabies vaccines administered intradermally using the Thai Red Cross regimen: investigation of the immunogenicity of serially diluted purified chick embryo cell rabies vaccine.
    Beran J; Honegr K; Banzhoff A; Malerczyk C
    Vaccine; 2005 Jun; 23(30):3902-7. PubMed ID: 15917111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
    Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
    Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
    Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS
    Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults.
    Ma J; Wang H; Li J; Chang L; Xie Y; Liu Z; Zhao Y; Malerczyk C
    Hum Vaccin Immunother; 2014; 10(10):2805-12. PubMed ID: 25483635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe.
    Kamoltham T; Thinyounyong W; Phongchamnaphai P; Phraisuwan P; Khawplod P; Banzhoff A; Malerczyk C
    J Pediatr; 2007 Aug; 151(2):173-7. PubMed ID: 17643772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity study of a new purified chick embryo cell rabies vaccine Vaxirab-N (Pitman-Moore strain) manufactured in India.
    Ashwath Narayana DH; Madhusudana SN; Sampath G; Tripathy RM; Sudarshan MK; Gangaboraiah ; Ravish HS; Satapathy DM; Gowda G; Holla R; Ashwin BY; Padhi A; Manjula S; Patel PM
    Hum Vaccin Immunother; 2014; 10(1):120-5. PubMed ID: 24030586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protecting Indian schoolchildren against rabies: pre-exposure vaccination with purified chick embryo cell vaccine (PCECV) or purified verocell rabies vaccine (PVRV).
    Shanbag P; Shah N; Kulkarni M; Juvekar M; Madhusudana SN; Vakil HB; Malerczyk C
    Hum Vaccin; 2008; 4(5):365-9. PubMed ID: 18398307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults.
    Kerdpanich P; Chanthavanich P; De Los Reyes MR; Lim J; Yu D; Ama MC; Mojares Z; Casula D; Arora AK; Pellegrini M
    PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006340. PubMed ID: 29874228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study on the immunogenicity and safety of a purified chick embryo cell rabies vaccine (PCECV) administered according to two different simulated post exposure intramuscular regimens (Zagreb versus Essen).
    Mahendra BJ; Narayana DA; Agarkhedkar S; Ravish HS; Harish BR; Agarkhedkar S; Madhusudana SN; Belludi A; Ahmed K; Jonnalagedda R; Vakil H; Bhusal C; Arora AK
    Hum Vaccin Immunother; 2015; 11(2):428-34. PubMed ID: 25692792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults.
    Roukens AH; Vossen AC; van Dissel JT; Visser LG
    Vaccine; 2008 Jun; 26(27-28):3438-42. PubMed ID: 18511158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study.
    Li R; Li Y; Wen S; Wen H; Nong Y; Mo Z; Xie F; Pellegrini M
    Hum Vaccin Immunother; 2015; 11(2):435-42. PubMed ID: 25692350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-exposure prophylaxis (PEP) for rabies with purified chick embryo cell vaccine: a systematic literature review and meta-analysis.
    Preiss S; Chanthavanich P; Chen LH; Marano C; Buchy P; van Hoorn R; Vonk Noordegraaf M; Mukherjee P
    Expert Rev Vaccines; 2018 Jun; 17(6):525-545. PubMed ID: 29939085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of saftey and immunogenicity of purified chick embryo cell rabies vaccine (PCECV) and purified vero cell rabies vaccine (PVRV) using the Thai Red Cross intradermal regimen at a dose of 0.1 ML.
    Madhusudana SN; Sanjay TV; Mahendra BJ; Sudarshan MK; Narayana DH; Giri A; Muhamuda K; Ravi V; Vakil HB; Malerczyk C
    Hum Vaccin; 2006; 2(5):200-4. PubMed ID: 17035734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine.
    Deshpande AK; Londhe VA; Akarte S; Briggs D
    J Assoc Physicians India; 2003 Jul; 51():655-8. PubMed ID: 14621031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection.
    Khawplod P; Wilde H; Sirikwin S; Benjawongkulchai M; Limusanno S; Jaijaroensab W; Chiraguna N; Supich C; Wangroongsarb Y; Sitprija V
    Vaccine; 2006 Apr; 24(16):3084-6. PubMed ID: 16494972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study.
    Sampath G; Banzhoff A; Deshpande A; Malerczyk C; Arora AK; Vakil H; Preiss S
    Hum Vaccin Immunother; 2017 Jul; 13(7):1531-1538. PubMed ID: 28406752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India.
    Sudarshan MK; Narayana DH; Madhusudana SN; Holla R; Ashwin BY; Gangaboraiah B; Ravish HS
    Hum Vaccin Immunother; 2012 Aug; 8(8):1077-81. PubMed ID: 22699446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-dermal administration of rabies vaccines in developing countries: at an affordable cost.
    Verma R; Khanna P; Prinja S; Rajput M
    Hum Vaccin; 2011 Jul; 7(7):792-4. PubMed ID: 21734465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.